О письме
McKinsey & Company отправил это письмо 16 июня 2026, 23:40. Тема: «AI in life sciences explained: The technology that could reinvent medicine». В архиве Валеры письмо сохранено как скриншот рассылки с адреса publishing@email.mckinsey.com. Ниже — краткий текстовый фрагмент для ознакомления и полный вид письма на скриншоте.
Текст письма
McKinsey & Company Share this email New from McKinsey & Company AI in life sciences explained: The technology that could reinvent medicine
Life sciences organizations have been using AI for years. Machine learning has guided drug discovery, and algorithms have long optimized manufacturing yields. But something is different about this current moment: the speed, scale, and depth of what’s now possible.
In this video Explainer , McKinsey’s Alex Devereson , Delphine Zurkiya , and Lieven Van der Veken draw on decades of experience advising pharma, biotech, and medtech companies to explore what AI actually means for the industry. They examine where real value is being captured today, why implementation so often falls short, what agentic AI makes possible that wasn’t conceivable before, and what a genuinely AI-transformed life sciences industry could look like within a decade.
Полный вид письма — на скриншоте.
Кнопки и ссылки в письме
- Alex Devereson
- Delphine Zurkiya
- privacy policy
